الفهرس | Only 14 pages are availabe for public view |
Abstract NSTEMI is one of the leading causes of death in patients with CAD. Increased levels of inflammatory markers have been found in association with the severity of coronary atherosclerosis and prognosis in acute coronary syndromes, the NLR is an indicator of baseline inflammatory response. Sx score was developed as part of the SYNTAX trial to quantify the severity and extent of CAD, Sx score has ability to predict adverse ischemic events in patients undergoing percutaneous coronary intervention (PCI) and provide a significant improvement in the process of risk stratification. We investigated whether there was an association between the NLR and severity of CAD in patients with NSTEMI using the Sx score |